The mean age of the dogs participating in the study was 31.9+7.4 months and 66% were male. Totally, 69% of the dogs of the different breeds involved in the study were owned. CoPV Ag was detected in 50% of the serum of dogs with papillomatous lesions (Table 1). On 25 animals whose CoPV Ag was found, treatment regimens were used. In the treatment 1 protocol, the remission period was determined as 21-30 days in 10 animals whose CoPV Ag presence was determined. In the treatment 2 protocol, this period was 15-30 days in 15 animals whose CoPV Ag presence was diagnosed. Lesions were successfully treated in all dogs with the presence of CoPV Ag in both groups (Table 2), (Fig 1-5).
The histological analysis revealed a substantial increase in the epidermal layer and marked epithelial proliferation. The thickness of epidermis was a characteristic finding. The proliferated epithelial cells included many keratohyalin granules. The keratinocytes of stratum granulosum or spinosum had big nuclei and some of the cells that were losing their nuclei displayed eosinophilic intranuclear inclusion bodies (Fig 6).
In both people and animals, papillomas that lead to recurring infections can result in benign and malignant tumors. Papillomas are more commonly localized in the head and neck areas of dogs. Whereas cutaneous papillomas are verrucous and hyperkeratotic; mucosal papillomas (eyes, mouth and other mucosal areas) are cauliflower-like lesions. The infection, which has no definitive treatment, heals spontaneously in 3-12 months if not intervened
(Williams et al., 2021; Chang et al., 2020; Yagci et al., 2008). Although papillomas are self-limiting, because of the prevention of feeding, CoPV-related anorexia and halitosis in dog hospices have been reported
(Lane et al., 2017; Yhee et al., 2010). CoPV1 was detected in a 3-year-old Labrador retriever dog and oral squamous cell carcinoma with oral papilloma malignant transformation originated at the level of the left mandibular first molar was reported (
Regalado Ibarra et al., 2018). It has been stated that more animals are affected in the outbreaks and the risk of malignancy increases in immunocompetent dogs. Therefore, it is important to develop an effective treatment to reduce secondary papilloma-related conditions. Studies have shown that environmental factors along with CoPV genotypes are important in malignant transformation
(Chang et al., 2020; Thaiwong et al., 2018). This situation reveals the necessity of effective treatment of lesions in a short time.
CoPV-induced papillomas in dogs are generally seen in the younger age group, regardless of breed or gender
(Head et al., 2002). Oral papillomas have been reported in dogs of all age groups
(Agut et al., 1996; Chang et al., 2020; Kalita et al., 2022; Nemec et al., 2014; Yhee et al., 2010). Contrary to this situation,
Thaiwong et al., (2018) examined 349 papilloma cases during the 10 years and determined the mean age as 8.5 in 9 malignant cases in which CoPV was detected.
Nemec et al., (2014) reported that ¾ of dogs with SCC were older than 6 years of age. This situation reveals that papillomas are more common and the risk of malignancy increases due to the decrease in immune response as age progresses. In our study, the average age of the dogs was determined as 31.9+7.4 months and there was no clustering in a certain age group.
Studies have revealed that no particular breed predisposes for CoPV infection. Cases have been reported in many dog breeds such as Labrador Retriever, Rottweiler, Cavalier King Charles Spaniel, Parson Russell Terrier and Newfoundland (
Regalado Ibarra et al., 2018). Papillomas were seen in many breeds such as Rottweiler, Cavalier King Charles Spaniel, Parson Russell Terrier, Newfoundland
(Bredal et al., 1996; Brandes et al., 2009). Although PVs are species specific, they do not differ in dog breeds. In this study, CoPV was detected in half of the dogs with papillomas belong the different breeds. Although the virus is species specific, it infects all dog breeds.
Although papillomas are self-limiting lesions, it is important to treat them because of their more frequent localization in the oral cavity, their prevalence and malignant transformation. Numerous researches have been done and are being done on various treatment methods. Surgical treatment can be chosen according to the size, distribution and localization of oral papillomas of dogs. However, studies on treatment protocols that provide ease of application come to the fore. For this purpose, immunomodulatory agents (imiquimod) are recommended (
Lange and Favrot, 2011). After the fifth dose, regression of papillomas was observed after intravenous administration of taurolidine (45 mg/kg) every 3 days to a 1-year-old coiled dog with clinical, histopathological and immunohistochemical CoPV detected
(Biricik et al., 2008). In medical treatments, it should contain antiviral effects and formulations to prevent recurrence. Such treatments will also shed light on the treatment of human papillomas.
Vaccination is the most effective and inexpensive way to prevent viral diseases. Vaccines are also used for therapeutic aim. Therefore, autogenous vaccines are more commonly used. Inactivation of autogenous vaccine obtained from infected tissue is done by various methods.
Agut et al., (1996) performed autogenous vaccine inactivation by temperature increase instead of formalin and reported that they achieved 100% success with vaccination in nine dogs aged between 3-7 years. At the same time, they reported that the development of chemical contamination could be prevented as a result of inactivation with heat
(Agut et al., 1996). The codon E2 vaccine obtained from CoPV E protein was found to be effective as a therapeutic vaccine
(Moore et al., 2003). Although studies have shown that vaccines are effective against papillomas, they are not commercially available in the market (
Lange and Favrot, 2011). In treatment 1, which is one of the treatment protocols compared in the study, 100% success was achieved in 10 animals that received autologous vaccine and immune-supportive Zylexis™. We speculate that humoral immunity developed in animals as a result of the application of this treatment protocol.
In young dogs, benign epithelial papillomas are more like cauliflower. As these lesions are widespread and break easily, many complications can be seen. It is important for the owners/caregivers of the animals that the treatment applications can be made easily in terms of the rapid regression and recovery of the disease. After the application of homeopathic agent (
Thuja occidentalis), injectable lithium antimony thiomalate, autohomeopathy and topical 15% zinc oxide protocol in CoPV infected dogs for four weeks, full recovery was observed and it was recommended as a treatment protocol
(Kalita et al., 2022). In another study, it was reported that the lesions regressed in a short time with azithromycin application and there was no recurrence in the 8-month follow-up period
(Yagci et al., 2008). Marins (2011) reported that combined therapy (autogenous vaccine,
Thuja occidentalis homeopathy and immunotherapy) was successful in CoPV-infected dogs and no recurrence was observed in the two-year follow-up period. In a study investigating the experimental effects of topical antiviral agents, 2% cidofovir ointment was found to be effective in the treatment of cottontail rabbit papillomavirus
(Christensen et al., 2014). Divya et al., (2015) reported that combined treatment including Thuja (homeopathy), autoimmune therapy (serum) and topical application of podowart, apple cider vinegar was ineffective in Rottweiler dog with massive papilloma lesion on the face. After this treatment, a rapid recovery and regression of papillomas have been reported after five doses of lithium antimony thiomolate at a dose of 0.5 ml intramuscularly
(Divya et al., 2015).